Akili Interactive, a startup that has developed a video game to help treat attention-deficit disorders in kids, has agreed to go public through a merger with one of Chamath Palihapitiya’s blank-check companies.
The deal, which confirms a Bloomberg News report, values the combined entity at about $1 billion, Akili and Social Capital Suvretta Holdings Corp. I said in a statement seen by Bloomberg. It will provide as much as $412 million in gross cash proceeds, the companies said. [Read more…] about Digital therapeutics pioneer Akili Interactive plans to go public in mid-2022 at a $1B valuation
attention deficit hyperactivity disorder
Managing attention deficit disorder by training the brain (ScienceDaily):
Attention Deficit Hyperactivity Disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood. This neurodevelopmental disorder is characterised by concentration difficulties, increased distractibility, impulsivity and hyperactivity. Today, ADHD is treated with pharmaceutical drugs that may have unwanted side effects. This is why scientists from the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG), Switzerland, explored a new technique called ‘neurofeedback’, which enables ADHD patients to train their attention, based on instant feedback from the level of their brain activity. [Read more…] about Study shows promising results of EEG-based brain training in helping adults with ADHD
Akili raises $110m to build its digital therapeutics pipeline (pharmaforum):
EndeavorRx became the first and so far only approved prescription video game treatment in the US when it was cleared by the FDA last year to treat attention-deficit hyperactivity disorder (ADHD), and has also been given a green light in Europe. [Read more…] about Akili Interactive Labs raises $160M in equity and debt to transform cognitive healthcare via prescription videogame treatments
Multiple studies have indicated that, on average, youth with ADHD have poorer outcomes in young adulthood in multiple areas compared to their unaffected peers.
A limitation of these studies, however, is that they have not typically distinguished between individuals whose ADHD persists into adulthood from those where the condition remits. [Read more…] about Large study with twins highlights the limited role of genetics in mental health and the importance of effective early interventions for ADHD
ADHD drugs do not improve cognition in healthy college students (ScienceDaily):
“Contrary to popular belief across college campuses, attention deficit hyperactivity disorder (ADHD) medications may fail to improve cognition in healthy students and actually can impair functioning, according to a study by researchers at the University of Rhode Island and Brown University. [Read more…] about Think twice before taking Aderall for cognitive enhancement: It may actually impair working memory and other cognitive abilities
“The company behind the LearningRX “brain training” program has agreed to pay a $200,000 settlement and to stop making claims that its system is clinically proven to treat serious health conditions, or that it can [Read more…] about Brain training franchisor LearningRx settles FTC complaint about its marketing claims